SCHEMBL17737641

SCHEMBL17737641

c1ccc2cc(N(c3ccc4oc5ccccc5c4c3)c3ccc4oc5ccccc5c4c3)ccc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.47
ALDH1A1 P00352 7/20 0.47
MAPT P10636 6/20 0.47
HPGD P15428 5/20 0.47
NPC1 O15118 4/20 0.47
RAB9A P51151 3/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
AHR P35869 2/20 0.43
GLA P06280 3/20 0.41
HSD17B10 Q99714 2/20 0.41
TSHR P16473 1/20 0.41
HTT P42858 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
LMNA P02545 1/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C19 P33261 2/20 0.40
CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19998667 0.95 KDM4E (0.44) KDM4EALDH1A1MAPTHPGDNPC1
SCHEMBL17737643 0.95 KDM4E (0.46) KDM4EALDH1A1MAPTHPGDNPC1
SCHEMBL17740566 0.94 KDM4E (0.42) KDM4EALDH1A1MAPTHPGDNPC1
SCHEMBL27273186 0.93 MAPT (0.41) KDM4EALDH1A1MAPTHPGDNPC1
SCHEMBL24153778 0.92 MAPT (0.46) KDM4EALDH1A1MAPTHPGDNPC1
SCHEMBL21968720 0.91 MAPT (0.41) KDM4EALDH1A1MAPTHPGDNPC1
SCHEMBL15213402 0.91 HPGD (0.41) KDM4EALDH1A1MAPTHPGDNPC1
SCHEMBL18802509 0.91 MAPT (0.41) KDM4EALDH1A1MAPTHPGDNPC1
SCHEMBL14926295 0.91 MAPT (0.41) KDM4EALDH1A1MAPTHPGDNPC1
SCHEMBL17737613 0.90 KDM4E (0.45) KDM4EALDH1A1MAPTHPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10937969-B2 Material for organic electroluminescent device and organic electroluminescent device using the same SAMSUNG DISPLAY CO., LTD. (KR) 2021-03-02 US disclosed
US-20190288214-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2019-09-19 US disclosed
US-10347844-B2 Material for organic electroluminescent device and organic electroluminescent device using the same SAMSUNG DISPLAY CO., LTD. (KR) 2019-07-09 US disclosed
US-20160133849-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-05-12 US disclosed
US-20160133849-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10347844-B2 Material for organic electroluminescent device and organic electroluminescent device using the same MAOA, MAOB, AOC2 KDM4E 452/4885ALDH1A1 97/4885MAPT 835/4885
US-20190288214-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME MAOA, MAOB, AOC2 KDM4E 452/4885ALDH1A1 97/4885MAPT 835/4885
US-10937969-B2 Material for organic electroluminescent device and organic electroluminescent device using the same MAOA, MAOB, AOC2 KDM4E 452/4885ALDH1A1 97/4885MAPT 835/4885
US-20160133849-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME MAOA, MAOB, AOC2 KDM4E 452/4885ALDH1A1 97/4885MAPT 835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.